Duration and Quality of 1% Ropivacaine Ankle Blocks (AQAB)

East Limburg Hospital

Status: Completed

Conditions: Forefoot Surgery

Study type: Observational

Funder types: Other

Identifiers

NCT07078396

AQAB

Details and patient eligibility

About

The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality improvement program.

An ankle block with 1% ropivcaine and patient follow-up is part of the standard practice at Ziekenhuis Oost-Limburg.

Enrollment: 56 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who underwent unilateral elective forefoot surgery under ankle block with 1% ropivacaine between December 2023 and April 2024 at Ziekenhuis Oost-Limburg, Genk, Belgium.

Exclusion criteria

• Bilateral cases of forefoot surgery
• Preoperative use of steroids,
• Preexisting lower extremity neuropathy
• Failed blocks